NIRMAN AGRI GENETICS
Back to Balance Sheet
|
NIRMAN AGRI GENETICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹113 Cr | ₹44 Cr | ₹30 Cr | ₹5.96 Cr | ₹1.64 Cr |
What is the latest Total Liabilities ratio of NIRMAN AGRI GENETICS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹113 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹5.96 Cr |
| Mar2021 | ₹1.64 Cr |
How is Total Liabilities of NIRMAN AGRI GENETICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹113 Cr | 155.79 | |
| Mar2024 | ₹44 Cr | 48.28 | |
| Mar2023 | ₹30 Cr | 400.89 | |
| Mar2022 | ₹5.96 Cr | 263.07 | |
| Mar2021 | ₹1.64 Cr | - | |
Compare Total Liabilities of peers of NIRMAN AGRI GENETICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NIRMAN AGRI GENETICS | ₹34.1 Cr | -2.1% | -16.9% | -81.7% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,842.7 Cr | -0.5% | -16.8% | -18.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,307.8 Cr | 3.8% | 8.6% | -36% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,723.9 Cr | -3% | -9.2% | -24.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹917.2 Cr | 18.4% | -2.7% | -41.4% | Stock Analytics | |
| INDO US BIOTECH | ₹208.9 Cr | 1.8% | -26.6% | -40.4% | Stock Analytics | |
NIRMAN AGRI GENETICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NIRMAN AGRI GENETICS | -2.1% |
-16.9% |
-81.7% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses